BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33242137)

  • 1. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach.
    Kumar NA; Desouza A; Bhandare MS; Murugan JR; Khandelwal G; Chaudhari V; Ostwal V; Shrikhande SV
    Langenbecks Arch Surg; 2021 May; 406(3):613-621. PubMed ID: 33242137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction.
    Koufuji K; Shirouzu K; Aoyagi K; Yano S; Miyagi M; Imaizumi T; Takeda J
    Kurume Med J; 2005; 52(3):73-9. PubMed ID: 16422172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 13. Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction.
    Jeremiasen M; Walther B; Djerf P; Staël von Holstein C; Zilling T; Hermansson M; Falkenback D; Johansson J
    Am J Surg; 2019 Aug; 218(2):329-334. PubMed ID: 30635210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Honda M; Kaito A; Daiko H; Kinoshita T
    Anticancer Res; 2014 Aug; 34(8):4391-7. PubMed ID: 25075076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of surgical therapy of adenocarcinomas of the esophagogastric junction according to a standardized surgical resection technique.
    Meyer W; Popp M; Klinger L; Awad-Allah A; Gebhardt C
    Dig Surg; 2002; 19(4):269-74; discussion 275. PubMed ID: 12207069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis.
    Kamarajah SK; Phillips AW; Griffiths EA; Ferri L; Hofstetter WL; Markar SR
    Ann Surg Oncol; 2021 Dec; 28(13):8485-8494. PubMed ID: 34255246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.
    Papaxoinis G; Kamposioras K; Weaver JMJ; Kordatou Z; Stamatopoulou S; Germetaki T; Nasralla M; Owen-Holt V; Anthoney A; Mansoor W
    J Gastrointest Surg; 2019 Sep; 23(9):1729-1741. PubMed ID: 30671799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of adenocarcinomas of the gastro-esophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Feb; 22(2):597-603. PubMed ID: 25190126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.